Serious adverse events
|
Placebo |
Ticagrelor 90mg bd |
Ticagrelor 60mg bd |
Total subjects affected by serious adverse events
|
|
|
|
subjects affected / exposed
|
1757 / 6996 (25.11%) |
1918 / 6988 (27.45%) |
1853 / 6958 (26.63%) |
number of deaths (all causes)
|
329 |
333 |
290 |
number of deaths resulting from adverse events
|
11 |
5 |
14 |
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
|
|
|
|
Acinic cell carcinoma of salivary gland
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Acute myeloid leukaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Adenocarcinoma gastric
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Adenocarcinoma of colon
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
7 / 6988 (0.10%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 7 |
1 / 7 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Adenolymphoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Adrenal adenoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ameloblastoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anal cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Anaplastic large cell lymphoma T- and null-cell types
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Anogenital warts
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Astrocytoma malignant
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Atypical fibroxanthoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
B-cell lymphoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Basal cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
9 / 6988 (0.13%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 12 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Benign neoplasm of bladder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Benign neoplasm of thyroid gland
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Benign neoplasm of ureter
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Benign ovarian tumour
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Benign pancreatic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Benign renal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Benign salivary gland neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Benign soft tissue neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bile duct adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Bile duct cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Biliary neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
5 / 6988 (0.07%) |
15 / 6958 (0.22%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 5 |
0 / 15 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
4 / 6988 (0.06%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder papilloma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder transitional cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
3 / 6988 (0.04%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder transitional cell carcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder transitional cell carcinoma recurrent
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bone cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Bone cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Bone sarcoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bowen's disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Brain cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Brain neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
Brain neoplasm malignant
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Breast cancer female
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
7 / 6988 (0.10%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Breast cancer male
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Breast cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Breast cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Brenner tumour
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchial carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchioloalveolar carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervix cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervix carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervix carcinoma stage 0
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cholangiocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Cholesteatoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Choroid melanoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Chronic lymphocytic leukaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Chronic myeloid leukaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Clear cell renal cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Colon adenoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
7 / 6988 (0.10%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 7 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Colon cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
14 / 6988 (0.20%) |
14 / 6958 (0.20%) |
occurrences causally related to treatment / all
|
1 / 7 |
0 / 14 |
0 / 14 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Colon cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
7 / 6988 (0.10%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 9 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 5 |
0 / 5 |
Colon neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Colorectal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Colorectal cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diffuse large B-cell lymphoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Endometrial adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Endometrial cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Endometrial cancer stage I
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Epithelioid mesothelioma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Essential thrombocythaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Fallopian tube cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Fibroma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Follicle centre lymphoma, follicular grade I, II, III stage IV
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gallbladder adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gallbladder cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Gallbladder cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Gastric adenoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastric cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
8 / 6988 (0.11%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 10 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
Gastrointestinal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal stromal cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal stromal tumour
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal tract adenoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrooesophageal cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Glioblastoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
Glioblastoma multiforme
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
Haemangioma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hepatic cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
Hepatic cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
Hepatic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hepatocellular carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Hodgkin's disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypergammaglobulinaemia benign monoclonal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Inflammatory pseudotumour
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intestinal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Invasive ductal breast carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Large intestine benign neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Laryngeal cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Laryngeal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Laryngeal squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Leiomyoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Leiomyosarcoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lentigo maligna
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Leukaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lip and/or oral cavity cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
Lip neoplasm malignant stage unspecified
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lipoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lung adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Lung adenocarcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
Lung cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
14 / 6988 (0.20%) |
11 / 6958 (0.16%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 14 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 8 |
0 / 9 |
0 / 3 |
Lung carcinoma cell type unspecified recurrent
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lung carcinoma cell type unspecified stage I
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lung carcinoma cell type unspecified stage IV
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Lung neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lung neoplasm malignant
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
17 / 6988 (0.24%) |
10 / 6958 (0.14%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 17 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 9 |
0 / 5 |
Lymphoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
Lymphoma cutis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lymphoplasmacytoid lymphoma/immunocytoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Malignant anorectal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Malignant ascites
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Malignant fibrous histiocytoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Malignant melanoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 5 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
Malignant neoplasm of ampulla of Vater
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Malignant neoplasm of unknown primary site
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
Malignant peritoneal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Malignant pleural effusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mediastinum neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Melanocytic naevus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Meningioma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Meningioma benign
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metastases to bone
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metastases to central nervous system
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metastases to liver
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metastases to lung
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metastases to lymph nodes
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Metastases to pancreas
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Metastases to peritoneum
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metastatic bronchial carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
Metastatic carcinoma of the bladder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
Metastatic gastric cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 1 |
Metastatic malignant melanoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
Metastatic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Metastatic pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metastatic salivary gland cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metastatic squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Monoclonal gammopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myelofibrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myeloproliferative disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nasal neoplasm benign
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Neoplasm malignant
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
Neoplasm prostate
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neoplasm skin
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neuroendocrine carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
Neuroendocrine carcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neuroendocrine tumour
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Non-Hodgkin's lymphoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Non-Hodgkin's lymphoma recurrent
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Non-Hodgkin's lymphoma stage I
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Non-Hodgkin's lymphoma stage II
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Non-Hodgkin's lymphoma unspecified histology aggressive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Non-small cell lung cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Non-small cell lung cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Oesophageal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal adenocarcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Oesophageal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Oesophageal carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 6 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 0 |
Oncocytoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oral cavity cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oropharyngeal cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ovarian cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Ovarian cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
Ovarian cancer stage III
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ovarian germ cell teratoma benign
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pancoast's tumour
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Pancreatic carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 7 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
Pancreatic carcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
1 / 7 |
0 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 4 |
Pancreatic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Paranasal sinus neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Parathyroid tumour benign
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pelvic neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Penile squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Penis carcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peritoneal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pharyngeal cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pharyngeal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pituitary tumour benign
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Plasma cell myeloma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pleomorphic adenoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pleural mesothelioma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Pleural mesothelioma malignant
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Polycythaemia vera
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Prostate cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
37 / 6996 (0.53%) |
38 / 6988 (0.54%) |
29 / 6958 (0.42%) |
occurrences causally related to treatment / all
|
0 / 37 |
0 / 38 |
0 / 29 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
Prostate cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
8 / 6988 (0.11%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 8 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 3 |
Prostate cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Prostate cancer stage II
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Prostatic adenoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rectal adenocarcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rectal adenoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rectal cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Rectal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Rectosigmoid cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
Renal cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal cell carcinoma recurrent
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal oncocytoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Salivary gland adenoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Salivary gland cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Salivary gland cancer recurrent
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Salivary gland neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sarcoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sarcomatoid mesothelioma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Skin cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Small cell lung cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Small cell lung cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
Small intestine carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal cord neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Splenic marginal zone lymphoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Squamous cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
Squamous cell carcinoma of lung
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Squamous cell carcinoma of pharynx
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Squamous cell carcinoma of skin
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thyroid adenoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thyroid cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thyroid cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Thyroid neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tongue cancer metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tongue neoplasm malignant stage unspecified
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tonsil cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tonsillar neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Transitional cell carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 4 |
1 / 6 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Transitional cell carcinoma metastatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Tumour associated fever
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tumour haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
2 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tumour pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Undifferentiated nasopharyngeal carcinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ureteric cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urethral cancer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary tract neoplasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Uterine leiomyoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vascular disorders
|
|
|
|
Accelerated hypertension
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Angiodysplasia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Aortic aneurysm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
13 / 6996 (0.19%) |
19 / 6988 (0.27%) |
19 / 6958 (0.27%) |
occurrences causally related to treatment / all
|
0 / 13 |
0 / 20 |
0 / 19 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Aortic aneurysm rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
Aortic dissection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Aortic dissection rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Aortic rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Aortic stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Aortic thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Aorto-duodenal fistula
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arterial rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Arteriovenous fistula
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Circulatory collapse
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Deep vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
10 / 6988 (0.14%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 11 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetic vascular disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Essential hypertension
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Extremity necrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Femoral artery aneurysm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Femoral artery embolism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Femoral artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hot flush
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypertension
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
18 / 6996 (0.26%) |
8 / 6988 (0.11%) |
15 / 6958 (0.22%) |
occurrences causally related to treatment / all
|
1 / 18 |
0 / 8 |
0 / 15 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypertensive crisis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
12 / 6996 (0.17%) |
10 / 6988 (0.14%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 14 |
0 / 11 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypertensive emergency
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypotension
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
10 / 6988 (0.14%) |
9 / 6958 (0.13%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 10 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypothenar hammer syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypovolaemic shock
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Iliac artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intermittent claudication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Leriche syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lymphoedema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Malignant hypertension
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Orthostatic hypotension
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Penetrating atherosclerotic ulcer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral arterial occlusive disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
15 / 6996 (0.21%) |
17 / 6988 (0.24%) |
10 / 6958 (0.14%) |
occurrences causally related to treatment / all
|
0 / 18 |
0 / 17 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral artery aneurysm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
17 / 6996 (0.24%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 22 |
0 / 6 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral artery thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral circulatory failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Peripheral embolism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral ischaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 13 |
0 / 6 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral vascular disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Poor peripheral circulation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Shock
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Shock haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Steal syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Subclavian artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Subclavian artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Superior vena cava syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Temporal arteritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thrombophlebitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Varicose vein
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vasculitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Vena cava thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Venous insufficiency
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Venous thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
General disorders and administration site conditions
|
|
|
|
Asthenia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac death
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
Catheter site haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
2 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Chest discomfort
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Chest pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
6 / 6988 (0.09%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 6 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Death
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
42 / 6996 (0.60%) |
42 / 6988 (0.60%) |
34 / 6958 (0.49%) |
occurrences causally related to treatment / all
|
0 / 42 |
2 / 42 |
3 / 34 |
deaths causally related to treatment / all
|
0 / 42 |
2 / 42 |
3 / 34 |
Device battery issue
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Device breakage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Device defective
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Device dislocation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Device lead damage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Device lead issue
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Device malfunction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Device material issue
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Device occlusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Drowning
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Drug withdrawal syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Euthanasia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Fatigue
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gait disturbance
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
General physical health deterioration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Hernia obstructive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypothermia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Impaired healing
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Implant site pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Injection site bruising
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Malaise
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Medical device complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Multi-organ failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Non-cardiac chest pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
109 / 6996 (1.56%) |
115 / 6988 (1.65%) |
113 / 6958 (1.62%) |
occurrences causally related to treatment / all
|
0 / 118 |
3 / 122 |
1 / 124 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oedema peripheral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pyrexia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Stent-graft endoleak
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sudden cardiac death
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
33 / 6996 (0.47%) |
27 / 6988 (0.39%) |
27 / 6958 (0.39%) |
occurrences causally related to treatment / all
|
0 / 33 |
0 / 27 |
0 / 27 |
deaths causally related to treatment / all
|
0 / 33 |
0 / 27 |
0 / 27 |
Sudden death
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
6 / 6988 (0.09%) |
11 / 6958 (0.16%) |
occurrences causally related to treatment / all
|
1 / 9 |
0 / 6 |
0 / 11 |
deaths causally related to treatment / all
|
1 / 9 |
0 / 6 |
0 / 11 |
Systemic inflammatory response syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vessel puncture site haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Immune system disorders
|
|
|
|
Allergy to arthropod sting
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anaphylactic reaction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anaphylactic shock
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anti-neutrophil cytoplasmic antibody positive vasculitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Contrast media allergy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Drug hypersensitivity
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypersensitivity
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Reaction to food additive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sarcoidosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Reproductive system and breast disorders
|
|
|
|
Acquired hydrocele
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Acquired phimosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Benign prostatic hyperplasia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
26 / 6996 (0.37%) |
20 / 6988 (0.29%) |
25 / 6958 (0.36%) |
occurrences causally related to treatment / all
|
0 / 26 |
0 / 20 |
2 / 26 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Breast fibrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Calculus prostatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervical cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervical dysplasia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cystocele
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Endometrial hyperplasia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gynaecomastia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Menorrhagia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metrorrhagia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ovarian cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ovarian necrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Postmenopausal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Prostatic mass
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Prostatism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Prostatitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 7 |
1 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Prostatomegaly
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Uterine cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Uterine haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Uterine polyp
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Uterine prolapse
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Uterovaginal prolapse
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vaginal prolapse
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Varicocele
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Respiratory, thoracic and mediastinal disorders
|
|
|
|
Acute pulmonary oedema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Acute respiratory distress syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Acute respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
6 / 6988 (0.09%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
1 / 7 |
0 / 7 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 0 |
Aspiration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
Asthma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
9 / 6988 (0.13%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 12 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Atelectasis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchial haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchial hyperreactivity
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchial obstruction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchiectasis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchitis chronic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchospasm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Choking
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Chronic obstructive pulmonary disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
45 / 6996 (0.64%) |
54 / 6988 (0.77%) |
39 / 6958 (0.56%) |
occurrences causally related to treatment / all
|
0 / 65 |
1 / 74 |
1 / 62 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 5 |
0 / 2 |
Chronic respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cough
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diaphragmatic paralysis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diffuse panbronchiolitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dyspnoea
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
12 / 6996 (0.17%) |
29 / 6988 (0.41%) |
23 / 6958 (0.33%) |
occurrences causally related to treatment / all
|
1 / 12 |
11 / 30 |
8 / 24 |
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
Dyspnoea exertional
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Emphysema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Epiglottic cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Epiglottic oedema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Epistaxis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
20 / 6988 (0.29%) |
15 / 6958 (0.22%) |
occurrences causally related to treatment / all
|
1 / 2 |
16 / 21 |
12 / 17 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemoptysis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
1 / 1 |
5 / 6 |
2 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemothorax
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hydrothorax
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypoxia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Idiopathic pulmonary fibrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Interstitial lung disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
1 / 4 |
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Laryngeal oedema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lung consolidation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lung disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nasal polyps
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nasal septum deviation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nocturnal dyspnoea
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Obstructive airways disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Organising pneumonia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pharyngeal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pharyngeal oedema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pleural adhesion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pleural effusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
16 / 6996 (0.23%) |
2 / 6988 (0.03%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 18 |
0 / 3 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Pleurisy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pleuritic pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia aspiration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
5 / 6988 (0.07%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Pneumothorax
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumothorax spontaneous
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pulmonary arterial hypertension
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pulmonary congestion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pulmonary embolism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
17 / 6996 (0.24%) |
21 / 6988 (0.30%) |
17 / 6958 (0.24%) |
occurrences causally related to treatment / all
|
0 / 17 |
0 / 23 |
0 / 17 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 5 |
0 / 1 |
Pulmonary fibrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Pulmonary haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pulmonary hypertension
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pulmonary mass
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pulmonary oedema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 2 |
Respiratory arrest
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Respiratory distress
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 6 |
0 / 7 |
deaths causally related to treatment / all
|
1 / 3 |
0 / 2 |
0 / 3 |
Respiratory tract haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Respiratory tract inflammation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sleep apnoea syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thoracic haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tonsillar hypertrophy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vocal cord leukoplakia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Psychiatric disorders
|
|
|
|
Affective disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Alcohol abuse
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Alcoholism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anxiety
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bipolar I disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Completed suicide
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 2 |
1 / 3 |
0 / 0 |
Confusional state
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Conversion disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Delirium
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Depressed mood
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Depression
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
11 / 6988 (0.16%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 13 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Insomnia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Major depression
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mental status changes
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Panic attack
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Panic disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post-traumatic stress disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Psychiatric decompensation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Psychiatric symptom
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Psychotic behaviour
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Somatoform disorder cardiovascular
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Suicidal ideation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Suicide attempt
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Investigations
|
|
|
|
Blood electrolytes decreased
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Blood glucose decreased
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Blood pressure increased
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Blood urine present
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac stress test abnormal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Clostridium test positive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ejection fraction decreased
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Electrocardiogram abnormal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Glycosylated haemoglobin increased
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haematocrit decreased
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Liver function test abnormal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lymph node palpable
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Occult blood positive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Scan myocardial perfusion abnormal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Weight increased
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Injury, poisoning and procedural complications
|
|
|
|
Abdominal wound dehiscence
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Accidental overdose
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Acetabulum fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Alcohol poisoning
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anaemia postoperative
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anaesthetic complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anastomotic complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anastomotic stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anastomotic ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ankle fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
11 / 6958 (0.16%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arterial injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arterial restenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arthropod sting
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Back injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bone contusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bone fissure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Brain contusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Brain herniation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
Burns second degree
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Burns third degree
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Carbon monoxide poisoning
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Carotid artery restenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervical vertebral fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Chemical peritonitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Chest injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Clavicle fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Concussion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Contusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
1 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Craniocerebral injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
Cystitis radiation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Extradural haematoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
Face injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Facial bones fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Fall
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Femoral neck fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
4 / 6988 (0.06%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 4 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Femur fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
11 / 6988 (0.16%) |
11 / 6958 (0.16%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 11 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Fibula fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Foot fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Forearm fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Foreign body
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Fractured ischium
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gas poisoning
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal stoma complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gun shot wound
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haematuria traumatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hand fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Head injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Heat exhaustion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Heat stroke
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hip fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
5 / 6988 (0.07%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 5 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Humerus fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Incisional hernia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Incisional hernia, obstructive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Inflammation of wound
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intestinal anastomosis complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Joint capsule rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Joint dislocation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 6 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Joint injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Laceration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ligament injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ligament rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ligament sprain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Limb crushing injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Limb injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Limb traumatic amputation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lip injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lower limb fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lumbar vertebral fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Meniscus injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
5 / 6988 (0.07%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Multiple fractures
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Multiple injuries
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Muscle rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Muscle strain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neck injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Osteoradionecrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Overdose
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Pancreatic leak
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Patella fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pelvic fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral arterial reocclusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral artery restenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Periprosthetic fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumothorax traumatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Poisoning
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post gastric surgery syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post procedural complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post procedural fistula
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post procedural haematoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
3 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post procedural haematuria
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
3 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post procedural haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
11 / 6988 (0.16%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 11 |
4 / 12 |
2 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post procedural persistent drain fluid
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post-traumatic pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Postoperative ileus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Postoperative respiratory failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Postoperative thoracic procedure complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Postoperative wound complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Postpericardiotomy syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Procedural haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
6 / 6988 (0.09%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 4 |
2 / 7 |
2 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Procedural hypotension
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Procedural pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pubis fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pulmonary contusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Radial nerve injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Radiation dysphagia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Radius fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Remnant gastritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal haematoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rib fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
8 / 6988 (0.11%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 8 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Road traffic accident
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
Scapula fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Seroma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Skull fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Soft tissue injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal compression fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal cord injury cervical
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Splenic rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sternal fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Subdural haematoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
3 / 5 |
2 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Subdural haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Suture related complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tendon injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tendon rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thermal burn
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thoracic vertebral fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tibia fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
6 / 6988 (0.09%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Toxicity to various agents
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Traumatic haematoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
13 / 6988 (0.19%) |
10 / 6958 (0.14%) |
occurrences causally related to treatment / all
|
0 / 4 |
5 / 14 |
2 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Traumatic haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Traumatic haemothorax
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Traumatic intracranial haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
18 / 6988 (0.26%) |
17 / 6958 (0.24%) |
occurrences causally related to treatment / all
|
0 / 13 |
2 / 20 |
4 / 19 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
Traumatic spinal cord compression
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ulna fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Upper limb fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary retention postoperative
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary tract injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
VIIIth nerve injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vascular graft complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vascular graft occlusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vascular graft thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vascular injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vascular procedure complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vascular pseudoaneurysm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Venous injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Wound
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Wound dehiscence
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Wound haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Wrist fracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Congenital, familial and genetic disorders
|
|
|
|
Atrial septal defect
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac disorders
|
|
|
|
Acute coronary syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Acute left ventricular failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
Acute myocardial infarction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
28 / 6996 (0.40%) |
19 / 6988 (0.27%) |
20 / 6958 (0.29%) |
occurrences causally related to treatment / all
|
0 / 28 |
1 / 19 |
1 / 20 |
deaths causally related to treatment / all
|
0 / 26 |
1 / 17 |
1 / 17 |
Adams-Stokes syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Angina pectoris
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
51 / 6996 (0.73%) |
51 / 6988 (0.73%) |
45 / 6958 (0.65%) |
occurrences causally related to treatment / all
|
1 / 53 |
0 / 55 |
0 / 47 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Angina unstable
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Aortic valve disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Aortic valve stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arrhythmia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 2 |
Arrhythmia supraventricular
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arteriosclerosis coronary artery
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Atrial fibrillation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
67 / 6996 (0.96%) |
74 / 6988 (1.06%) |
94 / 6958 (1.35%) |
occurrences causally related to treatment / all
|
0 / 73 |
0 / 88 |
0 / 104 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Atrial flutter
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
16 / 6996 (0.23%) |
13 / 6988 (0.19%) |
14 / 6958 (0.20%) |
occurrences causally related to treatment / all
|
0 / 20 |
0 / 13 |
0 / 15 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Atrial tachycardia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Atrial thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Atrioventricular block
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Atrioventricular block complete
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
13 / 6996 (0.19%) |
3 / 6988 (0.04%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
2 / 14 |
0 / 3 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Atrioventricular block second degree
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
1 / 5 |
2 / 4 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bifascicular block
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bradyarrhythmia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bradycardia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
7 / 6988 (0.10%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 7 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bundle branch block left
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bundle branch block right
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac arrest
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
7 / 6988 (0.10%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
1 / 6 |
0 / 8 |
0 / 8 |
deaths causally related to treatment / all
|
1 / 4 |
0 / 5 |
0 / 5 |
Cardiac asthma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
58 / 6996 (0.83%) |
54 / 6988 (0.77%) |
53 / 6958 (0.76%) |
occurrences causally related to treatment / all
|
0 / 73 |
1 / 69 |
0 / 70 |
deaths causally related to treatment / all
|
0 / 13 |
0 / 4 |
0 / 7 |
Cardiac failure acute
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
4 / 6988 (0.06%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 4 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 6 |
0 / 1 |
0 / 3 |
Cardiac failure chronic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
14 / 6996 (0.20%) |
19 / 6988 (0.27%) |
11 / 6958 (0.16%) |
occurrences causally related to treatment / all
|
0 / 16 |
0 / 25 |
0 / 19 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 5 |
0 / 1 |
Cardiac failure congestive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
51 / 6996 (0.73%) |
70 / 6988 (1.00%) |
53 / 6958 (0.76%) |
occurrences causally related to treatment / all
|
0 / 60 |
0 / 97 |
0 / 79 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 14 |
0 / 5 |
Cardiac hypertrophy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac perforation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac tamponade
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac valve disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardiac ventricular thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cardio-respiratory arrest
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
6 / 6988 (0.09%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 7 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 6 |
0 / 5 |
0 / 6 |
Cardiogenic shock
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
4 / 6988 (0.06%) |
9 / 6958 (0.13%) |
occurrences causally related to treatment / all
|
0 / 10 |
0 / 5 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 6 |
0 / 2 |
0 / 8 |
Cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Cardiopulmonary failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Cardiovascular insufficiency
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
1 / 1 |
0 / 1 |
0 / 0 |
Conduction disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cor pulmonale chronic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Coronary artery disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
6 / 6988 (0.09%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Coronary artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Coronary artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Coronary artery thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Dressler's syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrocardiac syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Heart valve incompetence
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intracardiac thrombus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ischaemic cardiomyopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
8 / 6988 (0.11%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 8 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Left ventricular dysfunction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Left ventricular failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
Low cardiac output syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mitral valve calcification
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mitral valve incompetence
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mitral valve prolapse
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myocardial fibrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myocardial infarction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
10 / 6988 (0.14%) |
9 / 6958 (0.13%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 10 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 11 |
0 / 10 |
0 / 9 |
Myocardial ischaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Myocardial oedema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myocardial rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Myocarditis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nodal arrhythmia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nodal rhythm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Palpitations
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pericardial effusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pericardial haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pericarditis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pulseless electrical activity
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Right ventricular failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sick sinus syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
8 / 6988 (0.11%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
1 / 8 |
0 / 9 |
1 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sinoatrial block
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sinus arrest
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sinus arrhythmia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sinus bradycardia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
12 / 6988 (0.17%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 7 |
4 / 12 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sinus tachycardia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Subendocardial ischaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Supraventricular extrasystoles
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Supraventricular tachycardia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 5 |
1 / 4 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Systolic dysfunction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tachyarrhythmia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tachycardia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tachycardia paroxysmal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ventricular arrhythmia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Ventricular dysfunction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ventricular extrasystoles
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
3 / 6988 (0.04%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ventricular fibrillation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
4 / 6988 (0.06%) |
11 / 6958 (0.16%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 4 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 5 |
Ventricular tachycardia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
12 / 6996 (0.17%) |
17 / 6988 (0.24%) |
17 / 6958 (0.24%) |
occurrences causally related to treatment / all
|
1 / 12 |
0 / 20 |
1 / 20 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
Nervous system disorders
|
|
|
|
Amyotrophic lateral sclerosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Brain injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Brain oedema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Brain stem infarction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
Brain stem syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Carotid arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Carotid artery aneurysm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Carotid artery disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Carotid artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
15 / 6988 (0.21%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 17 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Carotid sinus syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Carpal tunnel syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cauda equina syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Central nervous system lesion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cerebellar ataxia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cerebral arteriosclerosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Cerebral cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cerebral haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
1 / 5 |
0 / 2 |
2 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
1 / 1 |
Cerebral infarction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
Cerebral ischaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cerebral microangiopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cerebrospinal fluid leakage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cerebrovascular accident
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
Cerebrovascular disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervical cord compression
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervical myelopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervical radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervicobrachial syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cluster headache
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cognitive disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Complex regional pain syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Convulsion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Dementia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Dementia Alzheimer's type
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Demyelinating polyneuropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetic neuropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dizziness
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
9 / 6988 (0.13%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 10 |
1 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Epilepsy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 6 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Extrapyramidal disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Grand mal convulsion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Guillain-Barre syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemorrhage intracranial
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
Haemorrhagic stroke
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
6 / 10 |
1 / 5 |
2 / 3 |
deaths causally related to treatment / all
|
3 / 6 |
0 / 3 |
1 / 1 |
Haemorrhagic transformation stroke
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Headache
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypercapnic coma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypertensive encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypoxic-ischaemic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
IIIrd nerve paralysis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intracranial aneurysm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intraventricular haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ischaemic cerebral infarction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Ischaemic stroke
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
18 / 6996 (0.26%) |
11 / 6988 (0.16%) |
11 / 6958 (0.16%) |
occurrences causally related to treatment / all
|
0 / 19 |
1 / 11 |
1 / 11 |
deaths causally related to treatment / all
|
0 / 12 |
0 / 8 |
1 / 9 |
Leukoencephalopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Loss of consciousness
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lumbar radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metabolic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Migraine
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mononeuritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Monoparesis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Multiple sclerosis relapse
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Muscle contractions involuntary
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myelopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myoclonus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nerve root compression
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neuralgia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neuritis cranial
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neuropathy peripheral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Normal pressure hydrocephalus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Occipital neuralgia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Orthostatic intolerance
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Paraesthesia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Parkinson's disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Parkinsonism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peripheral nerve paresis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Polyneuropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Presyncope
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
3 / 6988 (0.04%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 6 |
1 / 3 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Psychomotor hyperactivity
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Quadriparesis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Radiculopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ruptured cerebral aneurysm
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Sciatica
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Senile dementia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Serotonin syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Somnolence
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal claudication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal cord compression
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Status epilepticus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Subarachnoid haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
Syncope
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
28 / 6996 (0.40%) |
37 / 6988 (0.53%) |
31 / 6958 (0.45%) |
occurrences causally related to treatment / all
|
0 / 30 |
3 / 39 |
1 / 33 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Temporal lobe epilepsy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tension headache
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Toxic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Transient global amnesia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Transient ischaemic attack
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Trigeminal neuralgia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Uraemic encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
VIIth nerve paralysis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
VIth nerve paresis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vagus nerve disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vascular encephalopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vascular parkinsonism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vertebral artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vertebrobasilar insufficiency
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Blood and lymphatic system disorders
|
|
|
|
Anaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
12 / 6988 (0.17%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 9 |
5 / 12 |
1 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anaemia macrocytic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anaemia megaloblastic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anaemia of chronic disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anaemia of malignant disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 7 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anaemia vitamin B12 deficiency
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Aplastic anaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Coagulation factor deficiency
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Coagulopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Febrile neutropenia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemolysis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemorrhagic anaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
1 / 2 |
2 / 4 |
2 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Heparin-induced thrombocytopenia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypercoagulation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypochromic anaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Immune thrombocytopenic purpura
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Increased tendency to bruise
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Iron deficiency anaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
24 / 6988 (0.34%) |
11 / 6958 (0.16%) |
occurrences causally related to treatment / all
|
2 / 3 |
10 / 25 |
3 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Leukocytosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Leukopenia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lymphadenopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Microcytic anaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
4 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nephrogenic anaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neutropenia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Normochromic normocytic anaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pancytopenia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pernicious anaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Splenic haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Splenomegaly
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spontaneous haematoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
1 / 3 |
1 / 2 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spontaneous haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thrombocytopenia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
8 / 6988 (0.11%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
5 / 8 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ear and labyrinth disorders
|
|
|
|
Acute vestibular syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Auricular perichondritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Deafness
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Deafness unilateral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Inner ear disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Meniere's disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Middle ear effusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Presbyacusis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sudden hearing loss
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tympanic membrane perforation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vertigo
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 8 |
1 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vertigo labyrinthine
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vertigo positional
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 7 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Eye disorders
|
|
|
|
Age-related macular degeneration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Angle closure glaucoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Blindness unilateral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cataract
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
14 / 6996 (0.20%) |
10 / 6988 (0.14%) |
16 / 6958 (0.23%) |
occurrences causally related to treatment / all
|
0 / 17 |
0 / 11 |
0 / 18 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cataract nuclear
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Conjunctival haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
2 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetic retinopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
1 / 3 |
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diplopia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Endocrine ophthalmopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Extraocular muscle paresis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Eye haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
2 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Eyelid ptosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Glaucoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Macular degeneration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Macular fibrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Open angle glaucoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Opsoclonus myoclonus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Optic ischaemic neuropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pterygium
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Retinal artery embolism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Retinal artery occlusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Retinal degeneration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Retinal detachment
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Retinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Retinal vein occlusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Strabismus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tolosa-Hunt syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vitreous haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
2 / 2 |
1 / 1 |
2 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal disorders
|
|
|
|
Abdominal adhesions
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abdominal discomfort
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abdominal hernia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abdominal hernia obstructive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abdominal pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
7 / 6988 (0.10%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
1 / 4 |
0 / 7 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abdominal pain lower
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abdominal pain upper
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abdominal wall haematoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Acute abdomen
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
Anal fissure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anal fistula
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anal polyp
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anal stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Appendiceal mucocoele
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ascites
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Barrett's oesophagus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Colitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Colitis ischaemic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Colitis ulcerative
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Constipation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
9 / 6988 (0.13%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 9 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Crohn's disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dental caries
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diaphragmatic hernia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diarrhoea
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
7 / 6988 (0.10%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 7 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dieulafoy's vascular malformation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diverticular perforation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Diverticulitis intestinal haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
3 / 5 |
1 / 1 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diverticulum
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
8 / 6988 (0.11%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
2 / 9 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diverticulum intestinal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diverticulum intestinal haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
11 / 6988 (0.16%) |
12 / 6958 (0.17%) |
occurrences causally related to treatment / all
|
1 / 2 |
8 / 12 |
12 / 15 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Duodenal stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Duodenal ulcer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
3 / 5 |
2 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Duodenal ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
7 / 6988 (0.10%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
3 / 4 |
5 / 7 |
5 / 7 |
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
Duodenitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dyspepsia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dysphagia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Enteritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Enterocolitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Enterocolitis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
2 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Enterovesical fistula
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Erosive duodenitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Erosive oesophagitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Faecalith
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Femoral hernia, obstructive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Food poisoning
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastric haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastric perforation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastric polyps
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastric ulcer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
13 / 6988 (0.19%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
2 / 4 |
6 / 14 |
4 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastric ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
18 / 6988 (0.26%) |
14 / 6958 (0.20%) |
occurrences causally related to treatment / all
|
4 / 7 |
13 / 18 |
9 / 14 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastric ulcer perforation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
Gastritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
17 / 6988 (0.24%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
1 / 11 |
3 / 18 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastritis atrophic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastritis erosive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastritis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
2 / 3 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastritis hypertrophic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastroduodenitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastroduodenitis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal angiodysplasia haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal erosion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
26 / 6988 (0.37%) |
15 / 6958 (0.22%) |
occurrences causally related to treatment / all
|
7 / 9 |
13 / 27 |
12 / 15 |
deaths causally related to treatment / all
|
1 / 2 |
0 / 4 |
1 / 1 |
Gastrointestinal mucosal disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal necrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Gastrointestinal pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal perforation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal polyp haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
1 / 3 |
1 / 2 |
1 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
5 / 6988 (0.07%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 5 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal vascular malformation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrooesophageal reflux disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
10 / 6996 (0.14%) |
11 / 6988 (0.16%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 11 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gingival bleeding
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haematemesis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haematochezia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemorrhagic erosive gastritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
1 / 3 |
3 / 3 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemorrhoidal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
2 / 3 |
2 / 4 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemorrhoids
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
2 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hiatus hernia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ileus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Ileus paralytic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Impaired gastric emptying
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 12 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Inguinal hernia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
21 / 6996 (0.30%) |
25 / 6988 (0.36%) |
26 / 6958 (0.37%) |
occurrences causally related to treatment / all
|
0 / 22 |
0 / 25 |
0 / 27 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Inguinal hernia strangulated
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Inguinal hernia, obstructive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intestinal infarction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Intestinal ischaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
Intestinal obstruction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
1 / 5 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
Intestinal perforation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Intussusception
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Irritable bowel syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Large intestinal ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Large intestine perforation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Large intestine polyp
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
12 / 6988 (0.17%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 12 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lower gastrointestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
1 / 2 |
2 / 3 |
2 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mallory-Weiss syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 4 |
2 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mechanical ileus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Melaena
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
1 / 2 |
3 / 4 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mouth haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nausea
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal achalasia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal obstruction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal ulcer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophageal varices haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophagitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Oesophagitis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pancreatic duct obstruction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pancreatic fistula
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pancreatic mass
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pancreatitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
7 / 6988 (0.10%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 8 |
1 / 7 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
Pancreatitis acute
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
8 / 6988 (0.11%) |
10 / 6958 (0.14%) |
occurrences causally related to treatment / all
|
1 / 7 |
1 / 8 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pancreatitis chronic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pancreatitis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Papilla of Vater stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Parotid gland inflammation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peptic ulcer haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
1 / 1 |
2 / 4 |
2 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peritoneal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Proctitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Proctitis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rectal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
5 / 6988 (0.07%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
2 / 5 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rectal polyp
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Reflux gastritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Small intestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Small intestinal obstruction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Small intestinal perforation
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Thrombosis mesenteric vessel
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tongue blistering
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tooth disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Toothache
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Umbilical hernia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Umbilical hernia, obstructive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Upper gastrointestinal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
7 / 6988 (0.10%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 7 |
5 / 7 |
deaths causally related to treatment / all
|
1 / 1 |
0 / 0 |
0 / 0 |
Volvulus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Volvulus of small bowel
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Vomiting
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hepatobiliary disorders
|
|
|
|
Acute hepatic failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bile duct stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bile duct stone
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
1 / 6988 (0.01%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
1 / 10 |
0 / 1 |
1 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Biliary colic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Biliary dyskinesia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Biliary fistula
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Biloma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cholangitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Cholangitis sclerosing
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cholecystitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
10 / 6988 (0.14%) |
17 / 6958 (0.24%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 10 |
0 / 17 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cholecystitis acute
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
7 / 6988 (0.10%) |
11 / 6958 (0.16%) |
occurrences causally related to treatment / all
|
0 / 11 |
0 / 7 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Cholecystitis chronic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cholelithiasis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
31 / 6996 (0.44%) |
15 / 6988 (0.21%) |
18 / 6958 (0.26%) |
occurrences causally related to treatment / all
|
0 / 31 |
0 / 15 |
0 / 18 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cholestasis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Chronic hepatitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cirrhosis alcoholic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Drug-induced liver injury
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gallbladder disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hepatic cirrhosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hepatic failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Hepatic vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Hepatomegaly
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hepatorenal failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hydrocholecystis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hyperplastic cholecystopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Jaundice
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Jaundice cholestatic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Liver disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Non-alcoholic steatohepatitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Portal vein thrombosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Skin and subcutaneous tissue disorders
|
|
|
|
Actinic keratosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Angioedema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
2 / 3 |
0 / 2 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cutaneous sarcoidosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Decubitus ulcer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dermal cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dermatitis allergic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetic foot
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Drug eruption
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dry gangrene
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ecchymosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Eczema
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hyperhidrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hyperkeratosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypersensitivity vasculitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Panniculitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Psoriasis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pyoderma gangrenosum
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rash
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rash generalised
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Skin haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Skin ulcer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Stevens-Johnson syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urticaria
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal and urinary disorders
|
|
|
|
Acute prerenal failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder diverticulum
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder neck sclerosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder prolapse
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bladder tamponade
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Calculus bladder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Calculus ureteric
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Calculus urethral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Calculus urinary
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cystitis haemorrhagic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cystitis noninfective
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetic nephropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Glomerulonephritis membranoproliferative
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Glomerulonephritis membranous
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haematuria
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
9 / 6988 (0.13%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
2 / 3 |
3 / 9 |
9 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemorrhage urinary tract
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
2 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hydronephrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypertensive nephropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nephritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nephrolithiasis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
21 / 6988 (0.30%) |
10 / 6958 (0.14%) |
occurrences causally related to treatment / all
|
0 / 12 |
2 / 22 |
0 / 11 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neurogenic bladder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Obstructive uropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pelvi-ureteric obstruction
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal artery stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal colic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal cyst ruptured
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal failure
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
15 / 6996 (0.21%) |
6 / 6988 (0.09%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 18 |
0 / 6 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 2 |
Renal failure acute
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
28 / 6996 (0.40%) |
32 / 6988 (0.46%) |
32 / 6958 (0.46%) |
occurrences causally related to treatment / all
|
0 / 34 |
0 / 34 |
1 / 32 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
Renal failure chronic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 6 |
1 / 8 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
Renal haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal impairment
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
1 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Renal tubular acidosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Stress urinary incontinence
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tubulointerstitial nephritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Ureteric rupture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Ureteric stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urethral stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary bladder haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary bladder polyp
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary incontinence
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary retention
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary tract disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinoma
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Endocrine disorders
|
|
|
|
Autoimmune thyroiditis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Goitre
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hyperthyroidism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypothyroidism
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Inappropriate antidiuretic hormone secretion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Toxic nodular goitre
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Musculoskeletal and connective tissue disorders
|
|
|
|
Ankylosing spondylitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arthralgia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arthritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
10 / 6988 (0.14%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 10 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arthropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Back pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
8 / 6988 (0.11%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 8 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bone pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bursitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cervical spinal stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Chondrocalcinosis pyrophosphate
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Chondropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Costochondritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dupuytren's contracture
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Facet joint syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Fibromyalgia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Foot deformity
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Fracture malunion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Fracture nonunion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gouty arthritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Groin pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haemarthrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hand deformity
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intervertebral disc compression
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intervertebral disc degeneration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intervertebral disc disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intervertebral disc protrusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
14 / 6996 (0.20%) |
8 / 6988 (0.11%) |
10 / 6958 (0.14%) |
occurrences causally related to treatment / all
|
0 / 15 |
0 / 11 |
0 / 10 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Jaw cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Jaw disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Joint ankylosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Joint effusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lumbar spinal stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 5 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Meniscal degeneration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Mobility decreased
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Monarthritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Muscle haemorrhage
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Muscle hypertrophy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Muscle spasms
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Muscular weakness
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Musculoskeletal chest pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
20 / 6996 (0.29%) |
16 / 6988 (0.23%) |
22 / 6958 (0.32%) |
occurrences causally related to treatment / all
|
1 / 20 |
0 / 17 |
0 / 23 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Musculoskeletal pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myalgia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myalgia intercostal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myopathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myositis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neck pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Osteoarthritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
59 / 6996 (0.84%) |
54 / 6988 (0.77%) |
54 / 6958 (0.78%) |
occurrences causally related to treatment / all
|
0 / 62 |
0 / 57 |
0 / 59 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Osteonecrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Osteoporosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pain in extremity
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pain in jaw
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Periarthritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Polyarthritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Polymyalgia rheumatica
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Polymyositis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Psoriatic arthropathy
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Resorption bone increased
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rhabdomyolysis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rheumatoid arthritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rotator cuff syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
12 / 6988 (0.17%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 12 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sacroiliitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal column stenosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
9 / 6958 (0.13%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal osteoarthritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
7 / 6988 (0.10%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 8 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spinal pain
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spondylolisthesis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Spondylolysis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sympathetic posterior cervical syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Synovial cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Systemic lupus erythematosus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tendon calcification
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tendon disorder
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tendonitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Trigger finger
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Infections and infestations
|
|
|
|
Abdominal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Abdominal sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Abdominal wall abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abdominal wall infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abscess limb
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Abscess neck
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Acquired immunodeficiency syndrome
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Acute sinusitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Amoebiasis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Anal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Appendicitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
9 / 6996 (0.13%) |
7 / 6988 (0.10%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 9 |
0 / 7 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Appendicitis perforated
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Arthritis infective
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Atypical pneumonia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Avian influenza
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bacterial infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bacterial prostatitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bacterial pyelonephritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bartholin's abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Biliary sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Breast abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
19 / 6996 (0.27%) |
22 / 6988 (0.31%) |
10 / 6958 (0.14%) |
occurrences causally related to treatment / all
|
1 / 20 |
1 / 27 |
0 / 14 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchitis bacterial
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bronchopneumonia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
12 / 6988 (0.17%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 12 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
Bronchopulmonary aspergillosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Bursitis infective
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Campylobacter gastroenteritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cellulitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
14 / 6996 (0.20%) |
12 / 6988 (0.17%) |
17 / 6958 (0.24%) |
occurrences causally related to treatment / all
|
0 / 15 |
0 / 13 |
1 / 19 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cellulitis laryngeal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cellulitis of male external genital organ
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cerebral toxoplasmosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Chest wall abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cholangitis suppurative
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cholecystitis infective
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Chronic sinusitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Clostridium colitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Clostridium difficile colitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Clostridium difficile infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Clostridium difficile sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Colonic abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Congo-Crimean haemorrhagic fever
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Cystitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dengue fever
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Device related infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
2 / 6988 (0.03%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Device related sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetic foot infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetic gangrene
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diverticulitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
12 / 6996 (0.17%) |
11 / 6988 (0.16%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
1 / 12 |
0 / 12 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
Ear infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Emphysematous cholecystitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Encephalitis brain stem
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Endocarditis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Endocarditis bacterial
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Enteritis infectious
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Enterococcal sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Enterocolitis infectious
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Epididymitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Epiglottitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Erysipelas
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
7 / 6996 (0.10%) |
4 / 6988 (0.06%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 7 |
0 / 5 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Escherichia bacteraemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Escherichia pyelonephritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Escherichia sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Escherichia urinary tract infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Extradural abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Eye infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Furuncle
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gangrene
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
5 / 6988 (0.07%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 5 |
0 / 8 |
deaths causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
Gastritis viral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastroenteritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
18 / 6996 (0.26%) |
18 / 6988 (0.26%) |
15 / 6958 (0.22%) |
occurrences causally related to treatment / all
|
0 / 18 |
0 / 18 |
1 / 16 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastroenteritis bacterial
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastroenteritis norovirus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastroenteritis rotavirus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastroenteritis salmonella
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastroenteritis viral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gastrointestinal infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Gingivitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Groin abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Groin infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
H1N1 influenza
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Haematoma infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 2 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Helicobacter gastritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Helicobacter infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hepatitis A
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hepatitis viral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Herpes simplex meningoencephalitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Herpes zoster
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Incision site infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Infected dermal cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Infected fistula
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Infected skin ulcer
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
4 / 6988 (0.06%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Infectious colitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Infectious pleural effusion
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Infective exacerbation of chronic obstructive airways disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
2 / 6988 (0.03%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 2 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Influenza
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Intervertebral discitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Klebsiella sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Labyrinthitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Laryngitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Leishmaniasis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Listeria sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Liver abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lobar pneumonia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 3 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Localised infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Lower respiratory tract infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 2 |
Lower respiratory tract infection bacterial
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lung abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lung infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Lyme disease
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Malaria
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Meningitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Meningitis bacterial
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Muscle abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Myringitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nasal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Nasopharyngitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Necrotising fasciitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Neutropenic sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
Ophthalmic herpes zoster
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Orchitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Osteomyelitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
5 / 6988 (0.07%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 5 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Otitis externa
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Otitis media acute
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Otitis media chronic
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pancreatic abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Paraspinal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Parotitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pelvic abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Periodontitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
1 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Perirectal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Peritonitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 6 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 4 |
0 / 0 |
Peritonsillar abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pharyngeal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pilonidal cyst
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumococcal sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
1 / 1 |
Pneumocystis jirovecii pneumonia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
76 / 6996 (1.09%) |
77 / 6988 (1.10%) |
69 / 6958 (0.99%) |
occurrences causally related to treatment / all
|
1 / 83 |
0 / 86 |
1 / 72 |
deaths causally related to treatment / all
|
0 / 4 |
0 / 7 |
1 / 10 |
Pneumonia bacterial
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
11 / 6996 (0.16%) |
6 / 6988 (0.09%) |
15 / 6958 (0.22%) |
occurrences causally related to treatment / all
|
0 / 12 |
0 / 6 |
0 / 15 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 3 |
Pneumonia cytomegaloviral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia haemophilus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia influenzal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia legionella
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia necrotising
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia pneumococcal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
1 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia pseudomonal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia streptococcal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pneumonia viral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post procedural infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Post procedural pneumonia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Postoperative wound infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
8 / 6958 (0.11%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Proctitis infectious
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pseudomembranous colitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pseudomonal sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pseudomonas infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pulmonary sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Pulmonary tuberculosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pyelonephritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
4 / 6988 (0.06%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 4 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pyelonephritis acute
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Pyopneumothorax
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rectal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Respiratory tract infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
4 / 6996 (0.06%) |
4 / 6988 (0.06%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 4 |
0 / 4 |
0 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Respiratory tract infection viral
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Retroperitoneal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Rhinitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Salmonellosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Scrotal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
15 / 6996 (0.21%) |
17 / 6988 (0.24%) |
20 / 6958 (0.29%) |
occurrences causally related to treatment / all
|
0 / 16 |
0 / 18 |
0 / 20 |
deaths causally related to treatment / all
|
0 / 3 |
0 / 8 |
0 / 5 |
Septic necrosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Septic shock
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
6 / 6996 (0.09%) |
12 / 6988 (0.17%) |
7 / 6958 (0.10%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 12 |
0 / 7 |
deaths causally related to treatment / all
|
0 / 5 |
0 / 8 |
0 / 3 |
Sialoadenitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Sinusitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
4 / 6988 (0.06%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Skin infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Soft tissue infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Staphylococcal sepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Streptococcal abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Streptococcal infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Subacute endocarditis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Subcutaneous abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tonsillitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Toxoplasmosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tracheitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tracheobronchitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Tuberculosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 3 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Upper respiratory tract infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urethritis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary bladder abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary tract infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
15 / 6996 (0.21%) |
28 / 6988 (0.40%) |
27 / 6958 (0.39%) |
occurrences causally related to treatment / all
|
0 / 15 |
0 / 30 |
0 / 30 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urinary tract infection pseudomonal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Urosepsis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
19 / 6988 (0.27%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 19 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
Vestibular neuronitis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Viral diarrhoea
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Viral infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Wound abscess
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Wound infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
3 / 6996 (0.04%) |
6 / 6988 (0.09%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 3 |
0 / 7 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Wound infection bacterial
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Wound infection staphylococcal
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Yersinia infection
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metabolism and nutrition disorders
|
|
|
|
Abnormal loss of weight
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Decreased appetite
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
1 / 1 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Dehydration
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
8 / 6996 (0.11%) |
11 / 6988 (0.16%) |
9 / 6958 (0.13%) |
occurrences causally related to treatment / all
|
0 / 8 |
0 / 13 |
0 / 9 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetes mellitus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
13 / 6996 (0.19%) |
15 / 6988 (0.21%) |
15 / 6958 (0.22%) |
occurrences causally related to treatment / all
|
0 / 15 |
0 / 17 |
0 / 15 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetes mellitus inadequate control
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
13 / 6996 (0.19%) |
11 / 6988 (0.16%) |
12 / 6958 (0.17%) |
occurrences causally related to treatment / all
|
0 / 13 |
0 / 14 |
0 / 13 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Diabetic complication
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Diabetic ketoacidosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 2 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Electrolyte imbalance
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
Failure to thrive
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Gout
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
1 / 2 |
0 / 1 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypercalcaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hyperglycaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
5 / 6988 (0.07%) |
4 / 6958 (0.06%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 5 |
0 / 4 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hyperkalaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
3 / 6988 (0.04%) |
5 / 6958 (0.07%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 3 |
0 / 5 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
Hypocalcaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypoglycaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
5 / 6988 (0.07%) |
6 / 6958 (0.09%) |
occurrences causally related to treatment / all
|
0 / 6 |
0 / 5 |
0 / 6 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypokalaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypomagnesaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hyponatraemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
3 / 6988 (0.04%) |
2 / 6958 (0.03%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 4 |
0 / 2 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Hypovolaemia
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lactic acidosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Lactose intolerance
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
0 / 6988 (0.00%) |
1 / 6958 (0.01%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 1 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Malnutrition
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Metabolic acidosis
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
2 / 6996 (0.03%) |
2 / 6988 (0.03%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 2 |
0 / 2 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Obesity
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
1 / 6996 (0.01%) |
0 / 6988 (0.00%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 1 |
0 / 0 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Type 1 diabetes mellitus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
0 / 6996 (0.00%) |
1 / 6988 (0.01%) |
0 / 6958 (0.00%) |
occurrences causally related to treatment / all
|
0 / 0 |
0 / 1 |
0 / 0 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |
Type 2 diabetes mellitus
|
|
|
|
alternative dictionary used: MedDRA
17
|
|
|
|
subjects affected / exposed
|
5 / 6996 (0.07%) |
6 / 6988 (0.09%) |
3 / 6958 (0.04%) |
occurrences causally related to treatment / all
|
0 / 5 |
0 / 6 |
1 / 3 |
deaths causally related to treatment / all
|
0 / 0 |
0 / 0 |
0 / 0 |